BUZZ-Doximity climbs on upbeat annual forecast
Shares of telehealth firm Doximityrise 8.7% to $63.74 premarket Late on Thursday, company raised FY26 sales forecast to between $628 mln and $636 mln, from $619 mln and $631 mln projected earlierAnalysts estimate FY26 sales at be $628 mln - data compiled by LSEGQ1 sales of $145.9 mln above estimate of $139.5 mlnQ1 adjusted EPS of 36 cents compares with estimate of 30 cents Separately, Doximity acquires Montreal-based Pathway Medical, an AI-driven clinical reference startup, for up to $63 mlnAs of last close, stock up 9.6% YTD
Shares of telehealth firm Doximity (DOCS.N) rise 8.7% to $63.74 premarket Late on Thursday, company raised FY26 sales forecast to between $628 mln and $636 mln, from $619 mln and $631 mln projected earlier
Analysts estimate FY26 sales at be $628 mln - data compiled by LSEG
Q1 sales of $145.9 mln above estimate of $139.5 mln
Q1 adjusted EPS of 36 cents compares with estimate of 30 cents Separately, Doximity acquires Montreal-based Pathway Medical, an AI-driven clinical reference startup, for up to $63 mln
As of last close, stock up 9.6% YTD
